bortezomib
Aromatics
- Bortezomib was approved for medical use in the United States in 2003 and in Europe in 2004. Bortezomib, sold under the brand name Velcade among others, is an anti-cancer medication used to treat multiple myeloma and mantle cell lymphoma.. Reference standards of Bortezomib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
stdClass Object
(
[pname] => (R)-Hydroperoxy Des(boric Acid) Bortezomib
[catalogue_number] => PA 02 79660
[category_ids] => ,80,79,75,
[chemical_name] =>
[weight] => 372.42
[form] => C19H24N4O4
[cas] => 886979-78-8
[pslug] => 886979-78-8-r-hydroperoxy-des-boric-acid-bortezomib-pa0279660
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
(R)-Hydroperoxy Des(boric Acid) Bortezomib
Catalogue No.:PA 02 79660
Molecular Formula : C19H24N4O4
Molecular Weight : 372.42
stdClass Object
(
[pname] => (S)-Hydroperoxy Des(boric Acid) Bortezomib
[catalogue_number] => PA 02 79670
[category_ids] => ,75,79,80,
[chemical_name] =>
[weight] => 372.43
[form] => C19H24N4O4
[cas] => 886979-81-3
[pslug] => 886979-81-3-s-hydroperoxy-des-boric-acid-bortezomib-pa0279670
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
(S)-Hydroperoxy Des(boric Acid) Bortezomib
Catalogue No.:PA 02 79670
Molecular Formula : C19H24N4O4
Molecular Weight : 372.43